Bronchiolitis management by the Belgian paediatrician: Discrepancies between evidence-based medicine and practice

Acta Clinica Belgica

Volumn 58, Issue 2, 2003, Pages 98-105

  De Bilderling, G ^a   Bodart, E ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Bronchiolitis; Guidelines; Management; Respiratory syncitial virus

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; RIBAVIRIN;

ARTICLE; BELGIUM; BRONCHIOLITIS; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; OXYGEN SATURATION; PEDIATRICIAN; PHYSIOTHERAPY; PRESCRIPTION; PULSE OXIMETRY; QUESTIONNAIRE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; BELGIUM; BRONCHIOLITIS, VIRAL; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH CARE SURVEYS; HOSPITALIZATION; HUMANS; MALE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; QUESTIONNAIRES; RESPIRATORY THERAPY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0038457512     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wohl MEB. Bronchiolitis. In: Chernick V, Boat TF, editors. Kendig's disorders of the respiratory tract in children. Philadelphia: Mosby, Inc. 1998: p 473-82.
2. Rakshi K, Couriel JM. Management of acute bronchiolitis. Arch Dis Child. 1994;71:463-9.
3. Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalized with respiratory syncitial virus. Eur J Pediatr. 1998;157:215-20.
4. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282:1440-46
5. Adcock PM, Sanders CL, Marshall GS. Standardizing the care of bronchiolitis. Arch Pediatr Adolesc Med. 1998;152:739-44.
6. Perlstein PH, Kotagal UR, Bolling C, et al. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics. 1999;104:1334-41.
7. Brand PLP, Vaessen-Verberne AAPH. Differences in management of bronchiolitis between hospitals in The Netherlands. Eur J Pediatr. 2000;159:343-7.
8. Kimpen JLL, Schaad UB. Treatment of respiratory syncitial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases. Pediatr Infect Dis J. 1997;16:479-81.
9. Kneyber MCJ, Brandenburg AH, de Groot R, et al. Risk factors for respiratory syncitial virus associated apnoea. Eur J Pediatr. 1998;157:331-5.
10. Everard ML. Acute bronchiolitis and pneumonia in infancy resulting from the respiratory syncitial virus. In: Taussig LM, Landau LI, Eds. Pediatric respiratory medicine. St Louis: Mosby. 1999: p 580-95.
11. De Boeck K. Respiratory syncitial virus bronchiolitis: clinical aspects and epidemiology. Monaldi Arch Chest Dis. 1996;51:210-3.
12. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr. 1991;118:807-11.
13. Schuh S, Canny G, Reisman JJ, et al. Nebulized albuterol in acute bronchiolitis. J Pediatr. 1990;117:633-7.
14. Dobson JV, Stephens-Groff SM, McMahon SR, Stemmler MM, Brallier SL, Bay C. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics. 1998;101:361-8.
15. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Efficacy of bronchodilator therapy in bronchiolitis: a meta-analysis. Arch Pediatr Adolesc Med. 1996;150:1166-72.
16. Goodman BT, Chambers TL. Bronchodilators for bronchiolitis. Lancet. 1993;341:1380.
17. Ho L, Collis J, Landau LI, LeSouef PN. Effect of salbutamol on oxygen saturation in bronchiolitis. Arch Dis Child. 1991;66:1061-64.
18. Wang EEL, Milner AD, Allen U, Maj H. Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch Dis Child. 1992;67:289-93.
19. Sanchez I, Dekoster J, Powell RE, Wolstein R, Chernick V. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr. 1993;122:145-51.
20. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr. 1995;126:1004-7.
21. Bulow SM, Nir M, Levin E, et al. Prednisolone treatment of respiratory syncitial virus infection: a randomized controlled trial of 147 infants. Pediatrics. 1999;104:e77.
22. Wong JYW, Moon S, Beardsmore C, O'Callaghan C, Simpson J. No objective benefit from steroids inhaled via a spacer in infants recovering from bronchiolitis. Eur Respir J. 2000;15:388-94.
23. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: a metaanalysis. Pediatrics. 2000;105:e44.
24. Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH. Risk of secondary bacterial infection in infants hospitalized with respiratory syncitial viral infection. J Pediatr. 1988;113:266-71.
25. Andrade MA, Hoberman A, Glustein J, Paradise JL, Wald ER. Acute otitis media in children with bronchiolitis. Pediatrics. 1998;101:617-9.
26. Committee on infectious diseases. Reassessment of the indications for ribavirin therapy in respiratory syncitial virus infections. Pediatrics. 1996;97:137-40.
27. Gibson LE. Use of water vapor in the treatment of lower respiratory disease. Am Rev Respir Dis. 1974;110:100-3.
28. Webb MS, Martin JA, Cartlidge PH, Ng YK, Wright NA. Chest physiotherapy in acute bronchiolitis. Arch Dis Child. 1985;60:1078-9.
29. Dawson K. Rational prescribing for acute bronchiolitis. Pharmacoeconomics. 1995;8:9-13.
30. Langley J, Wang EEL, Law BJ, et al. Economic evaluation of respiratory syncitial virus infection in Canadian children: a pediatric investigators collaborative network on infections in Canada (PICNIC) study. J Pediatr. 1997;131:113-7.